{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:03:05Z","timestamp":1790344985718,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["101007757"],"award-info":[{"award-number":["101007757"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["493624887"],"award-info":[{"award-number":["493624887"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ero.2025.10.004","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:37:15Z","timestamp":1762598235000},"page":"100068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of abatacept on bone in patients with psoriatic arthritis\u2014results from a prospective interventional high-resolution imaging study (ABEPSA)"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0804-3198","authenticated-orcid":false,"given":"Alp","family":"Temiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek","family":"Yalcin-Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koray","family":"Tascilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Fagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Kleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ero.2025.10.004_bib0001","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ero.2025.10.004_bib0002","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ero.2025.10.004_bib0003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13075-020-2103-8","article-title":"Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research","volume":"22","author":"van der Heijde","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.ero.2025.10.004_bib0004","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1136\/annrheumdis-2017-211433","article-title":"The effects of structural damage on functional disability in psoriatic arthritis","volume":"76","author":"Kerschbaumer","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ero.2025.10.004_bib0005","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ero.2025.10.004_bib0006","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2016-210724","article-title":"Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis","volume":"76","author":"Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ero.2025.10.004_bib0007","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13075-018-1769-7","article-title":"Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial","volume":"20","author":"Strand","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.ero.2025.10.004_bib0008","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/annrheumdis-2012-201611","article-title":"Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial","volume":"72","author":"Conaghan","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ero.2025.10.004_bib0009","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.2010.132423","article-title":"A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis","volume":"70","author":"Finzel","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ero.2025.10.004_bib0010","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/annrheumdis-2012-201580","article-title":"Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors","volume":"72","author":"Finzel","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ero.2025.10.004_bib0011","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/art.42617","article-title":"Baricitinib improves bone properties and biomechanics in patients with rheumatoid arthritis: results of the prospective interventional BARE BONE trial","volume":"75","author":"Simon","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.ero.2025.10.004_bib0012","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/annrheumdis-2014-206347","article-title":"Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis","volume":"75","author":"Simon","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ero.2025.10.004_bib0013","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.41239","article-title":"Association of structural entheseal lesions with an increased risk of progression from psoriasis to psoriatic arthritis","volume":"74","author":"Simon","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.10.004_bib0014","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-019-1938-3","article-title":"Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients","volume":"21","author":"Simon","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ero.2025.10.004_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-018-1653-5","article-title":"Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study","volume":"20","author":"Kampylafka","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ero.2025.10.004_bib0016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13075-018-1691-z","article-title":"Simultaneous quantification of bone erosions and enthesiophytes in the joints of patients with psoriasis or psoriatic arthritis\u2014effects of age and disease duration","volume":"20","author":"Simon","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.ero.2025.10.004_bib0017","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nrrheum.2014.23","article-title":"High-resolution in vivo imaging of bone and joints: a window to microarchitecture","volume":"10","author":"Geusens","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"10.1016\/j.ero.2025.10.004_bib0018","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1093\/rheumatology\/keac073","article-title":"Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis","volume":"61","author":"\u00d8stergaard","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.ero.2025.10.004_bib0019","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3899\/jrheum.090352","article-title":"The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA hands","volume":"36","author":"\u00d8stergaard","year":"2009","journal-title":"J Rheumatol"},{"issue":"suppl 2","key":"10.1016\/j.ero.2025.10.004_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/rheumatology\/35.suppl_2.4","article-title":"Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers","volume":"35","author":"Van Riel","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.ero.2025.10.004_bib0021","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.semarthrit.2017.09.011","article-title":"Methods for segmentation of rheumatoid arthritis bone erosions in high-resolution peripheral quantitative computed tomography (HR-pQCT)","volume":"47","author":"Figueiredo","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ero.2025.10.004_bib0022","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1093\/rheumatology\/keaa313","article-title":"Effect of biologics on radiographic progression of peripheral joint in patients with psoriatic arthritis: meta-analysis","volume":"59","author":"Wu","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"235","key":"10.1016\/j.ero.2025.10.004_bib0023","doi-asserted-by":"crossref","first-page":"235ra60","DOI":"10.1126\/scitranslmed.3007764","article-title":"T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway","volume":"6","author":"Bozec","year":"2014","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.ero.2025.10.004_bib0024","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3899\/jrheum.090351","article-title":"Testing an OMERACT MRI scoring system for peripheral psoriatic arthritis in cross-sectional and longitudinal settings","volume":"36","author":"McQueen","year":"2009","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.10.004_bib0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13075-017-1364-3","article-title":"Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis","volume":"19","author":"Szentpetery","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.ero.2025.10.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265833","article-title":"Analysis of bone erosions in rheumatoid arthritis using HR-pQCT: development of a measurement algorithm and assessment of longitudinal changes","volume":"17","author":"Shiraishi","year":"2022","journal-title":"PLoS One"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:32:24Z","timestamp":1790343144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3050708125000928"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.10.004","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of abatacept on bone in patients with psoriatic arthritis\u2014results from a prospective interventional high-resolution imaging study (ABEPSA)","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100068"}}